Genmab A/S/ DK0010272202 /
| 20/06/2024 21:53:39 | Chg. +3.3600 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 258.4200USD | +1.32% | 1,346 Turnover: 338,296.0900 |
-Bid Size: - | -Ask Size: - | 17.04 bill.USD | - | - |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 66.64 DKK | -20.08% |
| EPS Diluted: | - DKK | -20.06% |
| Revenues per Share: | 249.32 DKK | 12.37% |
| Book Value per Share: | 478.40 DKK | 14.63% |
| Cash Flow per Share: | 111.69 DKK | 86.64% |
| Dividend per Share: | - DKK | - |
| Total | in mill. | |
| Revenues: | 16,474.00 DKK | 13.57% |
| Net Income: | 4,352.00 DKK | -20.18% |
| Operating Cash Flow: | 7,380.00 DKK | - |
| Cash and Cash Equivalents: | 14,867.00 DKK | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 26.97 | 32.34 |
| P/S Ratio: | 7.21 | 8.64 |
| P/BV ratio: | 3.76 | 4.50 |
| P/CF Ratio: | 16.09 | 19.29 |
| PEG: | -1.34 | -1.61 |
| Earnings Yield: | 3.71% | 3.09% |
| Dividend Yield: | - | - |
| Market Capitalization | ||
| Market Capitalization: | 17.04 bill. USD | 21.09 bill. USD |
| Free Float Market Cap.: | - USD | - USD |
| Market Cap. / Employee: | 7.73 mill. USD | 9.57 mill. USD |
| Shares Outstanding: | 66.07 mill. | |
Profitability
| Gross Profit Margin: | - |
| EBIT Margin: | 32.30% |
| Net Profit Margin: | 26.42% |
| Return on Equity: | 13.77% |
| Return on Assets: | 12.33% |
Financial Strength
| Liquidity I / Cash Ratio: | 598.51% |
| Liquidity II / Quick Ratio: | 800.16% |
| Liquidity III / Current Ratio: | 1,334.10% |
| Debt / Equity Ratio: | 11.64% |
| Dynam. Debt / Equity Ratio: | 49.85% |
Efficiency
| Employees: | 2,204 |
| Personal Expenses / Employee: | - DKK |
| Revenues / Employee: | 7,474,591.65 DKK |
| Net Income / Employee: | 1,974,591.65 DKK |
| Total Assets / Employee: | 16,011,343.01 DKK |
| * Fiscal Year End: | 31/12/2023 |
| Accounting Standard: | IFRS |
| Currency: | DKK |
